NCT04916704View on ClinicalTrials.gov

Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

December 22, 2024

Study Completion Date

December 22, 2025

Conditions
ANCA Associated Vasculitis
Trial Locations (1)

B15 2TH

University Hospitals Birmingham, Birmingham

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University Hospital Birmingham NHS Foundation Trust

OTHER